July 2024 – Page 217 – Get News Story

Masterbatch Market Size, Opportunities, Top Companies, Growth, Trends, Regional Analysis, Key Segments, and Forecast to 2028

“Browse 404 market data Tables and 50 Figures spread through 318 Pages and in-depth TOC on “Masterbatch Market””

The Masterbatch market is expanding rapidly, driven by demand for enhanced plastic properties in automotive, packaging, and consumer goods. Key growth regions include Asia-Pacific and Europe, with innovation in color and additive technologies leading the way

In terms of value, the masterbatch market is projected to reach USD 16.8 billion by 2028 from 12.9 billion in 2023, at a CAGR of 5.4% during the forecast period. Manufacturers of masterbatch from North America and Europe are focusing on expansion of their manufacturing facilities in economies that are emerging due to their tax benefits, cost-effective labor, low cost setup, and increasing demand for masterbatch. Masterbatch is available in granular shape for the ease of processing plastic products.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=168014686

Based on type, the masterbatch market is segmented based on type into color, additive, black, white, and filler. Color masterbatch accounts for a major share of the overall masterbatch market, as it is easily available and used extensively to process polymers. It is used in a wide range of applications because of its mechanical, heat resistance, and weather resistance properties. They are used in applications such as packaging, building & construction, automotive, consumer goods, textile, and agriculture.

Based on polymer, the masterbatch market is segmented into PP, LDPE & LLDPE, HDPE, PVC, PET, PS, PUR, and others. LDPE & LLDPE is projected to be the fastest-growing polymer segment in the overall market. These polymers are widely used for manufacturing packaging bags, general plastic films, medical packaging, mulch films, greenhouse & tunnel films, and pipes.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=168014686

Based on Application, the masterbatch market is segmented into packaging, building & construction, automotive, consumer goods, textile, agriculture, and others. Packaging is estimated to be the largest application of masterbatch. It is widely used for industrial and household purposes. Changes in lifestyle and globalization have triggered the demand for preservative-added food, beverages, courier services, and packaging products, which is driving the masterbatch market.

Among the various regions, Asia Pacific is estimated to be the largest and fastest-growing masterbatch market. The growing packaging industry, along with increasing demand for masterbatch from the retail industry, is projected to drive the market in the region. The Asia Pacific masterbatch market is defined by the presence of numerous small and large domestic players providing customized products and services to end-users that require various amounts of masterbatch.

The key players in the masterbatch market are Avient Corporation (US), Ampacet Corporation (US), LyondellBasell Industries Holdings B.V. (US), Cabot Corporation (US), Plastika Kritis S.A. (Greece), Plastiblends (India), Hubron International (UK), Tosaf Group Ltd (Israel), Penn Color, Inc. (US), and Americhem (US) are the leading providers of masterbatch globally. These companies have manufacturing facilities as well as dominant distribution networks across key regions, such as Asia Pacific, North America, and Europe.

Inquire Now: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=168014686

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/masterbatches-market-168014686.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Masterbatch Market Size, Opportunities, Top Companies, Growth, Trends, Regional Analysis, Key Segments, and Forecast to 2028

Urticaria Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Sanofi, Genentech, AstraZeneca, Kiniksa Pharmaceuticals, Ltd, United BioPhar

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Urticaria pipeline constitutes 20+ key companies continuously working towards developing 25+ Urticaria treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

“Urticaria Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Urticaria Market.

The Urticaria Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Urticaria Pipeline Report:

Companies across the globe are diligently working toward developing novel Urticaria treatment therapies with a considerable amount of success over the years.
Urticaria companies working in the treatment market are Allakos, AstraZeneca, Biosana, Celldex Therapeutics, Celltrion, Eli Lilly and Company, Genentech, GI Innovation/Yuhan, Regeneron, GlaxoSmithKline, Taiho Pharma, Glenmark Pharmaceuticals, Gossamer Bio, Kiniksa Pharmaceuticals, Mycenax Biotech, Novartis, Regeneron, Synermore Biologics, UCB Biopharma, United BioPharma, and others, are developing therapies for the Urticaria treatment

Emerging Urticaria therapies in the different phases of clinical trials are- Ligelizumab, Remibrutinib (LOU064), Tezepelumab, CDX-0159, GI-301, Dupilumab (DUPIXENT), UB-221, MTPS9579A, Lirentelimab (AK002), TAS5315, rilzabrutinib, GDC-0853, AZD1981, Desloratadine, and others are expected to have a significant impact on the Urticaria market in the coming years.
In March 2024, Celltrion has submitted a biologics license application (BLA) to the US Food and Drug Administration (FDA) for CT-P39, a biosimilar candidate to XOLAIR (omalizumab), aimed at treating chronic spontaneous urticaria (CSU). This submission marks a crucial step towards introducing an interchangeable biosimilar for CSU treatment. The BLA is supported by evidence, including data from a global Phase III clinical trial comparing CT-P39 to the reference therapy XOLAIR.
In January 2024, Evommune has initiated a Phase I first-in-human clinical trial for EVO756, a new oral treatment for chronic spontaneous urticaria (CSU). This trial aims to evaluate the tolerability, safety, and pharmacokinetics of EVO756 in both healthy adults and adult CSU patients. The randomized, placebo-controlled, double-blind study will examine single and multiple ascending doses (SAD and MAD) in healthy participants, while also including an open-label study for CSU patients.
In November 2023, Novartis’ remibrutinib successfully met all primary and secondary endpoints at 12 weeks in the Phase III REMIX-1 and REMIX-2 trials for adults with chronic spontaneous urticaria (CSU) who do not respond adequately to H1-antihistamines. Remibrutinib, a selective Bruton’s tyrosine kinase (BTK) inhibitor, works by inhibiting histamine release through the BTK pathway. This histamine release is responsible for CSU symptoms such as itching, hives, and swelling.

Urticaria Overview

Urticaria, commonly known as hives, is a skin condition characterized by the sudden appearance of red, itchy welts or wheals on the skin. These welts can vary in size and shape, often merging together to form larger areas of raised skin. Urticaria can be acute, lasting less than six weeks, or chronic, persisting for more than six weeks.

Get a Free Sample PDF Report to know more about Urticaria Pipeline Therapeutic Assessment-

https://www.delveinsight.com/report-store/urticaria-pipeline-insight

Emerging Urticaria Drugs Under Different Phases of Clinical Development Include:

Ligelizumab: Novartis
Remibrutinib (LOU064): Novartis
Tezepelumab: Amgen
CDX-0159: Celldex Therapeutics
GI-301: GI Innovation
Dupilumab (DUPIXENT): Sanofi/ Regeneron
UB-221: United BioPharma
MTPS9579A: Genentech
Lirentelimab (AK002): Allakos Inc.
TAS5315: Taiho Pharma
rilzabrutinib: Sanofi
GDC-0853: Genentech, Inc.
AZD1981: AstraZeneca
Desloratadine: Organon and Co

Urticaria Route of Administration

Urticaria pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as

Oral
Parenteral
Intravenous
Subcutaneous
Topical

Urticaria Molecule Type

Urticaria Products have been categorized under various Molecule types, such as

Recombinant fusion proteins
Small molecule
Monoclonal antibody
Peptide
Polymer
Gene therapy

Urticaria Pipeline Therapeutics Assessment

Urticaria Assessment by Product Type
Urticaria By Stage and Product Type
Urticaria Assessment by Route of Administration
Urticaria By Stage and Route of Administration
Urticaria Assessment by Molecule Type
Urticaria by Stage and Molecule Type

DelveInsight’s Urticaria Report covers around 25+ products under different phases of clinical development like

Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration

Further Urticaria product details are provided in the report. Download the Urticaria pipeline report to learn more about the emerging Urticaria therapies

Some of the key companies in the Urticaria Therapeutics Market include:

Key companies developing therapies for Urticaria are – Sanofi, Genentech, AstraZeneca, Kiniksa Pharmaceuticals, Ltd, United BioPharma, Roche, Novartis, GlaxoSmithKline, Allakos, Eli Lilly and Company and others.

Urticaria Pipeline Analysis:

The Urticaria pipeline report provides insights into

The report provides detailed insights about companies that are developing therapies for the treatment of Urticaria with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Urticaria Treatment.
Urticaria key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Urticaria Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Urticaria market.

The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Urticaria drugs and therapies

Urticaria Pipeline Market Drivers

Treatment Side Effects with Currently Available Treatment, Economic Burden on Patients, Increase in Research and Development Activities, Increasing Market Size, are some of the important factors that are fueling the Urticaria Market.

Urticaria Pipeline Market Barriers

However, Lack of Understanding of Disease Pathology, Approaching Patent Cliff, and other factors are creating obstacles in the Urticaria Market growth.

Scope of Urticaria Pipeline Drug Insight

Coverage: Global
Key Urticaria Companies: Allakos, AstraZeneca, Biosana, Celldex Therapeutics, Celltrion, Eli Lilly and Company, Genentech, GI Innovation/Yuhan, Regeneron, GlaxoSmithKline, Taiho Pharma, Glenmark Pharmaceuticals, Gossamer Bio, Kiniksa Pharmaceuticals, Mycenax Biotech, Novartis, Regeneron, Synermore Biologics, UCB Biopharma, United BioPharma, and others
Key Urticaria Therapies: Ligelizumab, Remibrutinib (LOU064), Tezepelumab, CDX-0159, GI-301, Dupilumab (DUPIXENT), UB-221, MTPS9579A, Lirentelimab (AK002), TAS5315, rilzabrutinib, GDC-0853, AZD1981, Desloratadine, and others
Urticaria Therapeutic Assessment: Urticaria current marketed and Urticaria emerging therapies
Urticaria Market Dynamics: Urticaria market drivers and Urticaria market barriers

Request for Sample PDF Report for Urticaria Pipeline Assessment and clinical trials

Table of Contents

1. Urticaria Report Introduction

2. Urticaria Executive Summary

3. Urticaria Overview

4. Urticaria- Analytical Perspective In-depth Commercial Assessment

5. Urticaria Pipeline Therapeutics

6. Urticaria Late Stage Products (Phase II/III)

7. Urticaria Mid Stage Products (Phase II)

8. Urticaria Early Stage Products (Phase I)

9. Urticaria Preclinical Stage Products

10. Urticaria Therapeutics Assessment

11. Urticaria Inactive Products

12. Company-University Collaborations (Licensing/Partnering) Analysis

13. Urticaria Key Companies

14. Urticaria Key Products

15. Urticaria Unmet Needs

16 . Urticaria Market Drivers and Barriers

17. Urticaria Future Perspectives and Conclusion

18. Urticaria Analyst Views

19. Appendix

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: +14699457679
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Urticaria Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Sanofi, Genentech, AstraZeneca, Kiniksa Pharmaceuticals, Ltd, United BioPhar

Software-defined Vehicle Market Size worth USD 419.7 billion by 2028, at a CAGR of 9.1%

“Software-defined Vehicle Market”

Software-defined Vehicle Market by Offering (Hardware, Software, Services), Vehicle Type (ICE, BEV, HEV/PHEV), Vehicle Autonomy (Level 0, Level 1, Level 2, Level 3, Level 4, Level 5), Application and Region – Global Forecast to 2028

The software-defined vehicle market is projected to grow from USD 270.9 billion in 2023 to USD 419.7 billion by 2028, registering a CAGR of 9.1% during the forecast period. The market growth is attributed to the continued development of connected vehicles and the introduction of 5G cellular connectivity projects. Furthermore, the emergence of ride-hailing and mobility-as-a-service platforms is expected to create lucrative opportunities for the market.

The ICE vehicle type segment is expected to account for the largest share of the software-defined vehicle market in 2023.

The ICE segment is a significant market for software-defined vehicles. The driving factors for the adoption of ICE SDVs include the need for improved fuel efficiency and emissions, in addition to the desire for more connected and autonomous vehicles and the increasing availability of software and computing power. Software-based ICE vehicles have various benefits, including improved fuel efficiency and emissions, new features and functionality, over-the-air updates, and autonomous driving. The software in ICE-based vehicles can control the speed, steering, braking, and the environment and decide how to get around safely. Further, these vehicles often include ADAS features, such as adaptive cruise control, lane departure warning, automatic emergency braking, and parking assist. These features rely on sensors, cameras, and software algorithms to enhance safety and convenience. For example, the Volvo XC90 is a luxury SUV with a turbocharged gasoline engine.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=187205966

Hardware is expected to account for the largest share of the software-defined vehicle market in 2023.

The hardware segment accounted for the largest share of the software-defined vehicle market in 2022, and a similar trend is expected to be witnessed during the forecast period. With increasingly standardized hardware and a narrowed technical gap, the automotive industry is likely to go through a similar development process. Due to the rise in the development of automotive technologies, the adoption of software-defined vehicles is also increasing. The hardware segment is divided into four sub-segments: ECU/DCU, sensors/actuators, power electronics, and others. This hardware plays a crucial role in shaping the behavior, capabilities, and user experience of modern vehicles.

Asia Pacific market is expected to witness the highest CAGR in the software-defined vehicle market during the forecast period.

Asia Pacific is projected to record the highest CAGR during the forecast period. One of the key drivers for the Asia Pacific software-defined vehicle market is the increased demand ADAS, particularly in China, Japan, India, and South Korea. China already has some regulations in place in this domain. Moreover, government promotions and schemes have led to an increase in electric vehicle production volumes over the years, which caters to domestic and overseas demand. Japan and China export electric vehicles across the globe.

Key players

Key players in the software-defined vehicle market include Robert Bosch GmbH (Germany), Nvidia Corporation (US), APTIV (Ireland), Valeo (France), Marelli Holdings Co., Ltd. (Japan), Continental AG (Germany), Volkswagen Group (Germany), Tesla (US), HARMAN International (US), BlackBerry Limited (US), among others.

Request Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=187205966

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/software-defined-vehicles-market-187205966.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Software-defined Vehicle Market Size worth USD 419.7 billion by 2028, at a CAGR of 9.1%

Temple Fade Unveils Cutting-Edge Trends and Insights with the Launch of http://TempleFade.com

Temple Fade is a premier online platform for insightful and inspiring content across various niches. In a recent update, the company unveiled cutting-edge trends and insights with the launch of http://TempleFade.com

Irving, MN – In a website post, Temple Fade unveiled cutting-edge trends and insights with the launch of http://TempleFade.com.

The professionals noted that Temple Fade’s tech section dives deep into the rapidly evolving world of technology. Articles cover everything from the newest gadgets to advancements in AI and cybersecurity. Each piece offers in-depth analysis, breaking down complex topics into accessible insights. For instance, readers can explore how emerging technologies like 5G are reshaping communication and connectivity or gain insights into the practical implications of incorporating smart home devices into daily life.

The technicians mentioned that in the lifestyle section, Temple Fade curates content that speaks to the varied interests of its audience. Topics range from health and wellness tips based on current research to guides on travel destinations and explorations of cultural trends. By focusing on enriching readers’ lives with both practical advice and thought-provoking content, Temple Fade ensures its articles are engaging and informative. This approach helps readers stay abreast of trends that affect their daily routines and personal interests.

The crew asserted that for homeowners and DIY enthusiasts, Temple Fade offers a wealth of inspiration and guidance. The home improvement section features practical tips, from renovating on a budget to incorporating sustainable practices into home design. Detailed articles provide step-by-step instructions, highlight innovative materials, and showcase real-life renovation projects. This empowers readers to enhance their living spaces with confidence, supported by expert advice and insights tailored to their needs.

The team said that beyond its main site, Temple Fade extends its reach through Tumblr: templefade-blog. This platform serves as an extension of the news site, offering additional content such as behind-the-scenes stories, interviews with experts, and interactive discussions. Temple Fade on Tumblr fosters a community where readers can delve deeper into topics of interest, share experiences, and engage directly with content creators and fellow enthusiasts. It’s a hub for ongoing conversations and a source of continuous learning and discovery.

The experts added that Temple Fade is active on Nextdoor: Temple Fade, focusing on neighborhood-centric engagement. This platform facilitates discussions tailored to local communities, covering topics like home improvement tips specific to regional challenges, updates on local events, and opportunities for neighbors to connect and collaborate. Temple Fade on Nextdoor enhances its commitment to providing relevant and valuable insights and fostering community cohesion and support.

About Temple Fade

Temple Fade is a leading online platform for insightful and inspiring content across various niches. From cutting-edge technology trends to enriching lifestyle insights and practical home improvement advice, it aims to empower its audience with knowledge that enhances their daily lives. With a commitment to providing engaging articles that explore diverse topics in-depth, Temple Fade serves as a reliable resource for those seeking to stay informed and inspired in today’s dynamic world. Join Temple Fade on a journey of discovery and empowerment through its comprehensive and thought-provoking content.

Media Contact
Company Name: Temple Fade
Contact Person: Matt
Email: Send Email
Phone: +1 (320)-276-4111
Address:3354 Newton Street
City: Irving
State: MN 56273
Country: United States
Website: https://templefade.com/

Bar with Private Room Offered by The Winslow in NYC’s East Village and Gramercy

The Winslow, a beloved bar and restaurant in the heart of New York City’s East Village and Gramercy areas, is delighted to offer private rooms for various events and celebrations.

The Winslow, a beloved bar and restaurant in the heart of New York City’s East Village and Gramercy areas, is delighted to offer private rooms for various events and celebrations. As one of the best bars with private rooms in NYC, The Winslow caters to those seeking an intimate and welcoming atmosphere for gatherings such as corporate events, birthday parties, bridal showers, baby showers, and engagement celebrations.

Located just minutes away from Union Square, The Winslow is easily accessible and provides a vibrant oasis for patrons to indulge in. With a passion for rugby, trivia, gin tastings, and festive gatherings, The Winslow seamlessly blends sports, entertainment, and culinary delights, creating a sanctuary for its guests.

“At The Winslow, we take pride in offering a unique and memorable experience for our patrons,” said Mark Tafoya, spokesperson for The Winslow. “Our private rooms and semi-private areas are designed to cater to a wide array of interests and events, ensuring that each visit is truly special.”

Versatile Spaces for Every Occasion

The Winslow stands out among bars with private rooms in New York City, offering a range of options to suit various needs. The back room, a popular choice for semi-private events, can accommodate up to 20 seated guests or 30-35 standing guests. With two glass window walls and sliding doors, the back room provides privacy while still allowing guests to feel connected to the main bar area.

For larger groups of 35-55 guests, the Communal High Top Area is an ideal choice. This semi-private space, located in the right half of the main bar area, can be stanchioned off and reconfigured to create ample floor space for mingling. The Banquette Seating Section, on the left half of the main bar, offers comfortable lower seating for up to 20 guests, perfect for sit-down dinners or showers.

The Nook, a versatile alcove directly across from the lively bar area, features a large communal table that can seat up to 10 guests. This space is perfect for intimate dinners or as a home base for guests coming and going throughout the night.

Unforgettable Experiences at The Winslow

The Winslow’s commitment to providing exceptional service and creating memorable experiences is evident in the glowing reviews from satisfied patrons. Tara Nair, who celebrated her birthday at The Winslow, raved about the fantastic atmosphere, well-crafted gin and tonics, and helpful, friendly staff.

Beth Osborne, who hosted a going-away gathering for a friend, praised The Winslow’s flexibility and attentive service, stating, “It would have been such a headache to try and settle up with them after the party, but The Winslow made sure that even the frazzled coordinator (read: me) had a great time that night.”

A Premier Destination for Private Events in NYC

With its prime location, excellent amenities, and dedication to creating unforgettable experiences, The Winslow has established itself as a top contender for those seeking private event spaces in New York City. From trivia nights to bottomless brunches, The Winslow caters to a diverse range of interests, ensuring that each guest feels truly special and pampered.

“We understand the importance of finding the perfect space for your event,” added Tafoya. “At The Winslow, we strive to make the booking process seamless and to accommodate all of our guests’ needs. We invite everyone to come and experience the warmth and hospitality that The Winslow is known for.”

For more information about private room bookings and events at The Winslow, please contact Mark Tafoya at https://thewinslownyc.com/bars-with-private-rooms/.

About The Winslow:

The Winslow is a neighborhood favorite in NYC’s East Village and Gramercy areas, offering delicious food, drink options, and private event spaces. With a passion for rugby, trivia, gin tastings, and festive gatherings, The Winslow creates a vibrant atmosphere where sports, entertainment, and culinary delights blend seamlessly. The bar and restaurant provide a range of private and semi-private areas, catering to various events and celebrations, from intimate dinners to large gatherings.

Media Contact
Company Name: The Winslow
Contact Person: Mark Tafoya
Email: Send Email
Phone: (212) 777-7717
Address:243 E 14th St
City: New York
State: NY
Country: United States
Website: https://thewinslownyc.com/

Leading the Way in Waste Management: BBB Septic & Portable Toilets Excels in Northwest Arkansas

BBB Septic & Portable Toilets continues to solidify its position as the leading provider of comprehensive waste management solutions in Northwest Arkansas.

BBB Septic & Portable Toilets continues to solidify its position as the leading provider of comprehensive waste management solutions in Northwest Arkansas. With a steadfast commitment to environmental responsibility and customer satisfaction, BBB Septic & Portable Toilets has consistently exceeded industry standards, earning the trust of both residential and commercial clients throughout the region.

“We are incredibly proud of the reputation we’ve built in Northwest Arkansas as a trusted partner in waste management,” said Jon Jouvenaux of BBB Septic. “Our commitment to excellence goes beyond simply meeting the needs of our clients. We strive to exceed their expectations with innovative solutions, reliable service, and a deep respect for our environment.”

In a region where the natural beauty of the Ozarks and the rapid growth of communities intersect, BBB Septic recognizes the importance of a comprehensive approach to waste management. They provide essential septic services in Northwest Arkansas and actively educate residents and businesses on best practices for septic system maintenance and the environmental impact of responsible waste disposal. This dual focus on service and education empowers the community to play an active role in preserving the pristine landscapes and waterways that define Northwest Arkansas.

Given the region’s unique geological makeup and delicate ecosystems, expert septic installation in NWA is a necessity. Improperly installed septic systems can lead to groundwater contamination and soil pollution and even pose health risks to residents. BBB Septic’s team of seasoned professionals understands the intricacies of the region’s terrain and regulatory requirements to ensure that every septic installation is not only functional and efficient but also environmentally sound. This commitment to excellence safeguards the well-being of individual properties and contributes to the overall health and sustainability of the region.

BBB Septic & Portable Toilets is built on a foundation of hard work, integrity, and a passion for protecting the environment. This dedication is evident in every aspect of their operation, from the state-of-the-art equipment they use to the ongoing training they provide their employees. They are constantly exploring ways to improve the efficiency and effectiveness of their services while minimizing their environmental impact. This forward-thinking approach has allowed them to stay ahead of the curve in the ever-evolving waste management industry.

To learn more about BBB Septic and their commitment to Northwest Arkansas, visit their website at bbbseptic.com. Here, homeowners and businesses can discover how the company is making a difference through expert septic solutions, sustainable practices, and community engagement.

Media Contact
Company Name: BBB Septic
Contact Person: Jon Jouvenaux
Email: Send Email
Phone: (479) 250-3657
Address:4149 Cook Rd. #1
City: Bentonville
State: AR
Country: United States
Website: https://bbbseptic.com

New Thought Media Network Adds Contemporary Positive Music & Talk Show

New Thought is the spiritual belief system characterized by belief in our unity with spirit, the power of our thoughts to change our lives and our world, and freedom from the dogma and restrictions of traditional religious belief systems.

Positive music, as the name implies, is any music of any genre that empowers, uplifts and inspires. Positive music can be positive because of the lyrics. It can also be positive because of how it makes you feel.

“Anything Anything POSI” and New Thought Media Network invite you to take part in the next generation of New Thought where you get to decide for yourself what music you find positive, empowering, and uplifting.

The show plays a more contemporary mix of all kinds of positive music, both “New Thought” and “secular” (since we’ re all one in spirit) and features guest interviews who speak to a more practical view of spirituality in today’s world.

The show airs on New Thought Media Network http://www.ntmedia.org

• Fridays 9:00-11:00pm MT

• Saturdays 7:00pm-9:00pm MT (replay)

• Archive of past shows: https://www.mixcloud.com/Anything_Anything/

Press Contacts:

Brian Black
Anything Anything POSI
IG: any.any.posi
anyanyposi@protonmail.com

Rev. Robert Brzezinski
New Thought Media Network
IG: newthoughtmedianetwork
info@ ntmedia.org

Media Contact
Company Name: Anything Anything POSI
Contact Person: Brian Black
Email: Send Email
Country: United States
Website: http://www.ntmedia.org

Green Ammonia Market to Expand at a CAGR of 72.9% by 2031 Owing to High Demand for Organic Fertilizers

“Skyquest Technology”

Green Ammonia Market Size, Share, Growth Analysis, By Gasifier Technology(Alkaline Water Electrolysis, Proton Exchange Membrane Electrolysis, and Solid Oxide Electrolysis), By Application(Power Generation, Transportation, Industrial Feedstocks, Fertilizer), By Region – Industry Forecast 2024-2031

Green Ammonia Market size was valued at USD 173.51 Million in 2022 and is expected to grow from USD 300 Million in 2023 to reach USD 23959.7 Million by 2031, at a CAGR of 72.9% during the forecast period (2024-2031).

The green ammonia market, which emphasizes the production of ammonia using renewable energy sources, is becoming a crucial component in the worldwide shift towards sustainability. The process entails the synthesis of hydrogen by electrolyzing water, using renewable energy as the power source, and then combining it with nitrogen from the air. This effectively eliminates the carbon emissions that are often associated with conventional methods of ammonia manufacturing. This market will prioritize the provision of a sustainable and cost-effective supply of ammonia, which is crucial to produce fertilizers and plays a vital role in mitigating global climate change.

Green ammonia is synthesized through the utilization of sustainable energy sources, like wind, solar, and hydroelectric power. This process provides numerous benefits, including carbon neutrality and reduced ecological impact. In addition, green ammonia may be utilized as a fuel for transportation, a system for carrying hydrogen, and a method for storing energy. This makes it a versatile and environmentally responsible option for enterprises that want to decrease their carbon emissions.

Download a detailed overview:

https://www.skyquestt.com/sample-request/green-ammonia-market

Increasing Applications in Various Industries Supporting Market Growth Ammonia is a highly prevalent chemical commodity globally and is mostly used in the agricultural industry as a fertilizer. Moreover, as technology continues to expand and develop, it has been discovered that green ammonia can be employed in other applications outside its current principalutilization in the fertilizer sector. Ammonia offers the advantage of generating zero carbon emissions whenutilized as a fuel. Its environmental credentials can be enhanced by producing ammonia through theutilization of renewable energy. Due to its lack ofsulfur traces and carbon emissions, it has become widely popular as a shipping and marine fuel in the transportation industry, leading to improved air quality and reduced particulate emissions.

Increasing Demand for Environmentally Friendly Fertilizers AugmentingSales

The widespread use of chemical fertilizers and pesticides has led to a significant decline in soil quality on a global scale. The market for organic fertilizers is growing rapidly due to the increasing need for sustainable agricultural practices. It reduces the development of hazards and carbon emissions. Major agrochemical firms are increasingly favouring eco-friendly and sustainable goods such as green ammonia. Therefore, the increasing need for environmentally friendly fertilizers to mitigate environmental risks and pollution is projected to drive the sales of green ammonia.

Request Free Customization of this report:

https://www.skyquestt.com/speak-with-analyst/green-ammonia-market

Siemens Energy, Fortescue Future Industries, and GeoPura built an ammonia cracker prototype in November 2022. It was developed to produce green hydrogen industrially, reduce climate change, and lower carbon emissions. The prototype delivered 200 kg of hydrogen daily using ammonia, sufficient to power 5-10 hydrogen fuel cell electric buses.

In September 2022, Uniper SE, Germany’s largest power and gas trader, and Vesta came to an agreement to extend an existing storage facility to construct the first green ammonia hub known as Greenpoint Valley in Northwest Europe. Uniper SE is keen on entering new markets specializing in ammonia and hydrogen production to be sustainable across the Northwest Europe region. These European initiatives will enhance green ammonia and hydrogen markets that should help drive up supply security.
In December 2023, Sembcorp Industries partnered with Sojitz Corp and Kyushu Electric Power to supply green ammonia from India to Japan. It will lower carbon emissions in Japan. The alliance supports Japan’s government’s goal of accomplishing net-zero emissions by 2050.

In 2022, US fertilizer maker LSB Industries signed agreements with thyssenkrupp Uhde USA and Bloom Energy. The plan was to create 30,000 tonnes of green ammonia per year at its Pryor, Oklahoma facility. Thyssenkrupp Uhde will design a small amount of Pryor’s conventional ammonia capacity as green ammonia.

View report summary and Table of Contents (TOC):

https://www.skyquestt.com/report/green-ammonia-market

Green ammonia is projected to be adopted as an industrial chemical by 2040, with significant growth anticipated in the green ammonia market. This is an outcome of heightened government efforts to attain minimal or no carbon emissions. The product is expected to become the main commodity for regionally delivering renewable energy. The market is expected to experience growth due to the increasing demand for green ammonia in many industries including transportation, refrigeration, power generation, and fertilizer. Moreover, there is an increasing demand for environmentally friendly ammonia in industrial feedstock materials, particularly in the production of pharmaceuticals.

Related Reports:

Industry 4.0 Market

Visit Our Website: https://www.skyquestt.com/

Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email: Send Email
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/green-ammonia-market

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Green Ammonia Market to Expand at a CAGR of 72.9% by 2031 Owing to High Demand for Organic Fertilizers

Fresh Pet Food Market to Grab Attention with an Impressive 10% CAGR through 2031

“Skyquest Technology”

Fresh Pet Food Market Size, Share, Growth Analysis, By Pet type(Dogs, Cats, Others), By Product Type(Fresh Wet Pet Food, Fresh Dry Pet Food, Fresh Semi-Moist Pet Food), By Ingredients(Animal-Based Proteins, Plant-Based Proteins (Carrots, Beet, Sweet Potato), By Sales Channel(Online Channel, Offline Channel (Supermarkets & hypermarkets, Convenience stores)), By Region – Industry Forecast 2024-2031

Fresh Pet Food Market size was valued at around USD 10.8 billion in 2022 and is expected to rise from USD 11.9 billion in 2023 to reach a value of USD 25.5 Billion by 2031, at a CAGR of 10% over the forecast period (2024–2031).

The Global Fresh Pet Food market has witnessed a transformational shift in the last few years since pet owners prefer less processed and more fresh food for their pet companions. Animals can easily digest fresh pet food as compared to foods containing processed ingredients, which make them feel full for a long time and ultimately allow them to maintain a healthy weight.

The millennials and the adults are the major drivers of fresh pet food since they prefer fresh foods and consumables that are less processed, following the trend for their companion animals as well. Hence, for their pets, they are increasingly preferring foods that increase their nutrition and overall well-being. With the growing trend of human health, pet food makers are also increasingly launching nutritious food products for pets in the form of treats, supplements, or foods. The top trends that are at present driving the pet food market include wellness/health and humanization. This has considerably increased the promotion of food products that include a wide range of functional advantages. These include weight management, dental health, and life-stage-specific advantages.

Download a detailed overview:

https://www.skyquestt.com/sample-request/fresh-pet-food-market

Addition of High-Proteins and Vegetables and Fruits in Pet Diet to Propel the Market

The pet food makers worldwide have more potential to attract a wider range of pet owner population by adding best nutrition and ingredients in pet food products. They are currently, majorly focusing on healthy aging, proper weight management, and more calmness like pets. Hence, such continued efforts by the pet food manufacturing companies are projected to accompany the new entrants and create more potential for supplying improved ingredients. For a balanced diet, pet food makers add less processed whole ingredients and avoid artificial additives or preservatives. Hence, such pet foods can offer a more balanced and complete diet than the traditionally supplied food products. Companies are making efforts to include high-quality protein like chicken, beef, turkey, fish, or lamb. These types of protein foods will offer the vital amino acids that the pet animals need to repair and build tissues, preserve muscle mass, and support better immune function. Also, fresh pet foods today contain a wide range of vegetables and fruits like carrots, spinach, apples, blueberries, and sweet potatoes. These ingredients have a good amount of antioxidants, minerals, and vitamins, supporting the pet’s eye health, protecting against damage to cells, and inflammation. Foods today also include healthy fats, like the ones present in fish, since they are beneficial in supporting healthy skin and the brain.

Request Free Customization of this report:

https://www.skyquestt.com/speak-with-analyst/fresh-pet-food-market

In February 2023, Mars Petcare firm, belonging to Mars, Incorporated, announced the acquisition of Champion Petfoods. The pioneer, Champion Petfoods is a great partner to Mars Petcare. The acquisition complements its global portfolio in pet nutrition, food products and health essentials.
In August 2022, Wellness Pet Company, a producer of premium natural treats and foods for cats and dogs revealed its recent work in the nutritional category at SuperZoo. The new offering emphasizes balanced and complete nutrition as these foods are specially produced to deliver optimal health benefits, selected with healthy ingredients for freshness, and then frozen to deliver nutrients.
In March 2024, PetPlate, a fresh dog food firm, announced a distribution expansion into above 700 PetSmart stores all over the United States. With this association, PetPlate with PetSmart, is hoping to introduce the growth of fresh pet food to the brick-and-mortar network.

View report summary and Table of Contents (TOC):

https://www.skyquestt.com/report/fresh-pet-food-market

As humanization is already an attractive innovation in the fresh pet food market, the trend has just started. Just like consumers are more inclined toward healthy food products and consumables, they are also preferring the same for their pet companions for their better digestion and overall health. Owners are willing to spend more on the nutrition of their pets and feed them the heathiest options available in the market. The trend will also strengthen animal-human bond, similar to the parent child bond.

Related Reports:

Internet of Things market

Visit Our Website: https://www.skyquestt.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Fresh Pet Food Market to Grab Attention with an Impressive 10% CAGR through 2031

Lassa Fever Market Poised for Significant Growth from 2023 to 2032, Reports DelveInsight | Inovio Pharma

The Lassa Fever market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Lassa Fever pipeline products will significantly revolutionize the Lassa Fever market dynamics.

DelveInsight’s “Lassa Fever Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Lassa Fever, historical and forecasted epidemiology as well as the Lassa Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Lassa Fever market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

To Know in detail about the Lassa Fever market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Lassa Fever Market Forecast

Some of the key facts of the Lassa Fever Market Report:

The Lassa Fever market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
As per data available on Orphanet, LF is endemic in West Africa. Lack of surveillance prohibits accurate estimates of incidence, but estimates range up to 300,000-500,000 infections and 5,000-10,000 cases of LF per year
As per WHO (n.d.), about 80% of people who become infected with Lassa virus have nosymptoms. 1 in 5 infections result in severe disease, where the virus affects several organs such as the liver, spleen and kidneys
Key Lassa Fever Companies: Inovio Pharmaceuticals, and others
Key Lassa Fever Therapies: INO-4500, and others
The Lassa Fever epidemiology based on severity analyzed that incidence of Lassa Fever in a study population is very low for severe cases

Lassa Fever Overview

Lassa fever is an acute viral hemorrhagic illness caused by the Lassa virus, a member of the Arenaviridae family. The disease is endemic in parts of West Africa, with the virus primarily transmitted to humans through contact with food or household items contaminated with rodent urine or feces, particularly from the Mastomys rat. Person-to-person transmission can also occur through direct contact with the blood, urine, feces, or other body fluids of infected individuals.

Get a Free sample for the Lassa Fever Market Report –

https://www.delveinsight.com/report-store/lassa-fever-market

Lassa Fever Market

The dynamics of the Lassa Fever market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.

“INO-4500 among others is one of the most anticipated emerging therapy that are awaiting launch. These emerging therapies are in early stage of clinical trials, and their approval will change the face of the market.”

Lassa Fever Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Lassa Fever Epidemiology Segmentation:

The Lassa Fever market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

Total Prevalence of Lassa Fever
Prevalent Cases of Lassa Fever by severity
Gender-specific Prevalence of Lassa Fever
Diagnosed Cases of Episodic and Chronic Lassa Fever

Download the report to understand which factors are driving Lassa Fever epidemiology trends @ Lassa Fever Epidemiological Insights

Lassa Fever Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Lassa Fever market or expected to get launched during the study period. The analysis covers Lassa Fever market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Lassa Fever Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Lassa Fever Therapies and Key Companies

INO-4500: Inovio Pharmaceuticals

To know more about Lassa Fever treatment, visit @ Lassa Fever Medications

Scope of the Lassa Fever Market Report

Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Lassa Fever Companies: Inovio Pharmaceuticals, and others
Key Lassa Fever Therapies: INO-4500, and others
Lassa Fever Therapeutic Assessment: Lassa Fever current marketed and Lassa Fever emerging therapies
Lassa Fever Market Dynamics: Lassa Fever market drivers and Lassa Fever market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Lassa Fever Unmet Needs, KOL’s views, Analyst’s views, Lassa Fever Market Access and Reimbursement

Discover more about therapies set to grab major Lassa Fever market share @ Lassa Fever Treatment Landscape

Table of Contents

1. Lassa Fever Market Report Introduction

2. Executive Summary for Lassa Fever

3. SWOT analysis of Lassa Fever

4. Lassa Fever Patient Share (%) Overview at a Glance

5. Lassa Fever Market Overview at a Glance

6. Lassa Fever Disease Background and Overview

7. Lassa Fever Epidemiology and Patient Population

8. Country-Specific Patient Population of Lassa Fever

9. Lassa Fever Current Treatment and Medical Practices

10. Lassa Fever Unmet Needs

11. Lassa Fever Emerging Therapies

12. Lassa Fever Market Outlook

13. Country-Wise Lassa Fever Market Analysis (2019–2032)

14. Lassa Fever Market Access and Reimbursement of Therapies

15. Lassa Fever Market Drivers

16. Lassa Fever Market Barriers

17. Lassa Fever Appendix

18. Lassa Fever Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lassa Fever Market Poised for Significant Growth from 2023 to 2032, Reports DelveInsight | Inovio Pharma